Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors
U.S. Consumer Confidence Edges Up in June, with Labor Market Concerns and Easing Inflation Coexisting
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response
